D
Bristol-Myers Squibb Company BMY
$59.01 -$1.27-2.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -95.91% -37.19% -18.96% -626.57% -12.86%
Total Depreciation and Amortization -24.50% 6.47% 7.23% 2.87% 0.04%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 252.58% -31.67% 145.12% 3,718.32% -15.30%
Change in Net Operating Assets 49.24% 486.60% -39.47% 114.56% 286.68%
Cash from Operations 4.40% 17.68% 23.26% -4.58% 28.61%
Capital Expenditure -14.55% 5.26% -1.16% -2.16% 4.62%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 91.91% -6.75% -646.20% -25,608.97% -400.86%
Divestitures 38.17% 3.24% 39.18% 6.17% -66.10%
Other Investing Activities 84.62% 1,700.00% 157.50% 690.12% -170.12%
Cash from Investing 85.44% 46.59% -300.91% -9,241.90% -210.96%
Total Debt Issued -109.59% 1,050.00% 183.48% 12,363.28% 3,004.41%
Total Debt Repaid 100.00% -- -1,207.95% -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -5.00% -2.10% -1.67% -1.34% -1.31%
Other Financing Activities -- -58.97% -111.32% -5.43% --
Cash from Financing -269.80% 25.35% -85.14% 580.13% 129.79%
Foreign Exchange rate Adjustments -288.46% 302.63% -175.00% -446.15% -17.89%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -37.89% 286.35% -387.64% -688.81% 188.82%
Weiss Ratings